IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 1, Issue 4 (2020)
J Clinic Care Skill 2020, 1(4): 153-157 |
Back to browse issues page
Article Type:
History
Received: 2019/10/9 | Accepted: 2020/01/6 | Published: 2020/07/23
Received: 2019/10/9 | Accepted: 2020/01/6 | Published: 2020/07/23
How to cite this article
Mohammadi H, Afkari M, Salehi N, Roozbehi A. Efficacy of Pregabalin on Reducing Pain in Patients with Lumbosacral Radiculopathy. J Clinic Care Skill 2020; 1 (4) :153-157
URL: http://jccs.yums.ac.ir/article-1-71-en.html
URL: http://jccs.yums.ac.ir/article-1-71-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Social Determinants of Health (SDH) Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
2- Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
2- Cellular and Molecular Research Center, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract (2719 Views)
Aims: Pregabalin is one of the anti-seizure and analgesic drugs, which is widely used in the treatment of neuropathic pain and chronic radiculopathy in the form of monotherapy. The aim of this study was to evaluate the effectiveness of pregabalin drug therapy with common treatment (an NSAID) on reducing pain in patients with lumbosacral radiculopathy.
Materials & Methods: In this clinical trial, 90 patients with lumbosacral radiculopathy referring to the clinic of Shahid Mofatteh, Yasuj, Iran in 2018, were selected using purposeful convenience sampling and divided into intervention (N=45) and control (N=45) groups. The pain severity was assessed by a standard visual analog scale (VAS). In the intervention group, 100 mg celecoxib every 12 hours, plus 75 mg per day pregabalin, and in the control group, 100 mg celecoxib every 12 hours, plus 75 mg per day pregabalin placebo were prescribed. After 8 weeks, the severity of the pain was again assessed and compared.
Findings: At the beginning of the study, the mean pain severity in the intervention and control group did not differ significantly (p>0.05). After the intervention, the mean pain severity between the two groups did not show a significant difference (p>0.05). The severity of the pain did not differ significantly between the two groups of intervention and control according to age, disease history, location of pain, and body weight (p>0.05).
Conclusion: The efficacy of pregabalin and NSAID in comparison with NSAID use in patients with lumbosacral radiculopathy is not different in reducing pain severity.Aims: Pregabalin is one of the anti-seizure and analgesic drugs, which is widely used in the treatment of neuropathic pain and chronic radiculopathy in the form of monotherapy. The aim of this study was to evaluate the effectiveness of pregabalin drug therapy with common treatment (an NSAID) on reducing pain in patients with lumbosacral radiculopathy.
Materials & Methods: In this clinical trial, 90 patients with lumbosacral radiculopathy referring to the clinic of Shahid Mofatteh, Yasuj, Iran in 2018, were selected using purposeful convenience sampling and divided into intervention (N=45) and control (N=45) groups. The pain severity was assessed by a standard visual analog scale (VAS). In the intervention group, 100 mg celecoxib every 12 hours, plus 75 mg per day pregabalin, and in the control group, 100 mg celecoxib every 12 hours, plus 75 mg per day pregabalin placebo were prescribed. After 8 weeks, the severity of the pain was again assessed and compared.
Findings: At the beginning of the study, the mean pain severity in the intervention and control group did not differ significantly (p>0.05). After the intervention, the mean pain severity between the two groups did not show a significant difference (p>0.05). The severity of the pain did not differ significantly between the two groups of intervention and control according to age, disease history, location of pain, and body weight (p>0.05).
Conclusion: The efficacy of pregabalin and NSAID in comparison with NSAID use in patients with lumbosacral radiculopathy is not different in reducing pain severity.Aims: Pregabalin is one of the anti-seizure and analgesic drugs, which is widely used in the treatment of neuropathic pain and chronic radiculopathy in the form of monotherapy. The aim of this study was to evaluate the effectiveness of pregabalin drug therapy with common treatment (an NSAID) on reducing pain in patients with lumbosacral radiculopathy.
Keywords:
References
1. Iversen T, Solberg TK, Romner B, Wilsgaard T, Nygaard Ø, Waterloo K, et al. Accuracy of physical examination for chronic lumbar radiculopathy. BMC Musculoskelet Disord. 2013;14:206. [link] [DOI:10.1186/1471-2474-14-206] [PMID] [PMCID]
2. Kasimcan O, Kaptan H. Efficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk hernia. Neurol Med Chir (Tokyo). 2010;50(12):1070-3. [link] [DOI:10.2176/nmc.50.1070] [PMID]
3. Tarulli AW, Raynor EM. Lumbosacral radiculopathy. Neurol Clin. 2007;25(2):387-405. [link] [DOI:10.1016/j.ncl.2007.01.008] [PMID]
4. Shahbandar L, Press J. Diagnosis and nonoperative management of lumbar disk herniation. Oper Tech Sports Med. 2005;13(2):114-21. [link] [DOI:10.1053/j.otsm.2005.08.002]
5. van der Windt DA, Simons E, Riphagen II, Ammendolia C, Verhagen AP, Laslett M, et al. Physical examination for lumbar radiculopathy due to disc herniation in patients with low‐back pain. Cochrane Database Syst Rev. 2010;(2):CD007431. [link] [DOI:10.1002/14651858.CD007431.pub2] [PMID]
6. Last AR, Hulbert K. Chronic low back pain: evaluation and management. Am Fam Physician. 2009;79(12):1067-74. [link]
7. Visco CJ, Cheng DS, Kennedy DJ. Pharmaceutical therapy for radiculopathy. Phys Med Rehabil Clin N Am. 2011;22(1):127-37. [link] [DOI:10.1016/j.pmr.2010.11.003] [PMID]
8. Atlas SJ, Nardin RA. Evaluation and treatment of low back pain: an evidence-based approach to clinical care. Muscle Nerve. 2003;27(3):265-84. [link] [DOI:10.1002/mus.10311] [PMID]
9. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147(7):505-14. [link] [DOI:10.7326/0003-4819-147-7-200710020-00008] [PMID]
10. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430-4. [link] [DOI:10.1136/bmj.332.7555.1430] [PMID] [PMCID]
11. Hegarty DA, Shorten GD. A Randomised, placebo-controlled trial of the effects of preoperative pregabalin on pain intensity and opioid consumption following lumbar discectomy. Korean J Pain. 2011;24(1):22-30. [link] [DOI:10.3344/kjp.2011.24.1.22] [PMID] [PMCID]
12. Kaye AD, Beuno FR, Katalenich B, Stell C, Liu H, Rosinia FA, et al. The effects of gastroretentive gabapentin (Gralise®) on spinal stenosis patients with radicular pain. Pain Physician. 2014;17(2):169-78. [link]
13. Yaksi A, Ozgönenel L, Ozgönenel B. The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine (Phila Pa 1976). 2007;32(9):939-42. [link] [DOI:10.1097/01.brs.0000261029.29170.e6] [PMID]
14. White PF, Tufanogullari B, Taylor J, Klein K. The effect of pregabalin on preoperative anxiety and sedation levels: a dose-ranging study. Anesth Analg. 2009;108(4):1140-5. [link] [DOI:10.1213/ane.0b013e31818d40ce] [PMID]
15. Gianesello L, Pavoni V, Barboni E, Galeotti I, Nella A. Perioperative pregabalin for postoperative pain control and quality of life after major spinal surgery. J Neurosurg Anesthesiol. 2012;24(2):121-6. [link] [DOI:10.1097/ANA.0b013e31823a885b] [PMID]
16. Burke SM, Shorten GD. Perioperative pregabalin improves pain and functional outcomes 3 months after lumbar discectomy. Anesth Analg. 2010;110(4):1180-5. [link] [DOI:10.1213/ANE.0b013e3181cf949a] [PMID]
17. Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, et al. PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial. Trials. 2013;14:2013. [link] [DOI:10.1186/1745-6215-14-213] [PMID] [PMCID]
18. Paech MJ, Goy R, Chua S, Scott K, Christmas T, Doherty DA. A randomized, placebo-controlled trial of preoperative oral pregabalin for postoperative pain relief after minor gynecological surgery. Anesth Analg. 2007;105(5):1449-53. [link] [DOI:10.1213/01.ane.0000286227.13306.d7] [PMID]
19. Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, et al. Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand. 2009;53(2):227-35. [link] [DOI:10.1111/j.1399-6576.2008.01821.x] [PMID]
20. Jokela R, Ahonen J, Tallgren M, Haanpää M, Korttila K. A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain. 2008;134(1-2):106-12. [link] [DOI:10.1016/j.pain.2007.04.002] [PMID]
21. Greco R, Tassorelli C, Sandrini G, Di Bella P, Buscone S, Nappi G. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia. 2008;28(2):114-26. [link]
22. Eipe N, Penning J, Ansari M, Yazdi F, Ahmadzai N. A protocol for systematic review for perioperative pregabalin use. Syst Rev. 2012;1(40):1-7. [link] [DOI:10.1186/2046-4053-1-40] [PMID] [PMCID]
23. Imani F, Rahimzadeh P. Gabapentinoids: gabapentin and pregabalin for postoperative pain management. Anesth Pain Med. 2012;2(2):52-3. [link] [DOI:10.5812/aapm.7743] [PMID] [PMCID]
24. Vadivelu N, Mitra S, Narayan D. Recent advances in postoperative pain management. Yale J Biol Med. 2010;83(1):11-25. [link]
25. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain- -a systematic review of randomized controlled trials. Pain. 2006;126(1-3):91-101. [link] [DOI:10.1016/j.pain.2006.06.018] [PMID]
26. Hill CM, Balkenohl M, Thomas DW, Walker R, Mathé H, Murray G. Pregabalin in patients with postoperative dental pain. Eur J Pain. 2001;5(2):119-24. [link] [DOI:10.1053/eujp.2001.0235] [PMID]
27. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618-25. [link] [DOI:10.1016/S0140-6736(06)68700-X]